RxDoctor Payments Data

William Sides, MD

Family Medicine · Gardendale, ALNPI 1215255344

Payments from drug & device makers

$1,372in general payments, 2019–2025

Across 74 payments — averaging $18.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$223
  • Pfizer$200
  • AbbVie$129
  • AstraZeneca$128
  • GSK$101
  • Amgen$93
  • plus $498 from 13 others

What the payments were for

  • Food & beverage$1,372100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,372 in reported general payments places this provider in the 60th percentile of 1,680 family medicine providers in Alabama.

See all family medicine providers in Alabama

Medicare billing

Part B allowed, 2024
$101,812
Medicare patients
337
Services billed
1,961

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin100$92,454
OzempicSemaglutide48$53,924
XareltoRivaroxaban42$37,686
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog56$34,664
RybelsusSemaglutide23$32,983
EliquisApixaban39$27,418
JanumetSitagliptin Phos/Metformin Hcl21$23,072
Janumet XrSitagliptin Phos/Metformin Hcl18$18,609
Breo ElliptaFluticasone/Vilanterol25$14,578
JanuviaSitagliptin Phosphate15$14,434
Tresiba Flextouch U-100Insulin Degludec25$13,605
FarxigaDapagliflozin Propanediol12$9,516
Atorvastatin Calcium602$8,225
Lantus SolostarInsulin Glargine,hum.Rec.Anlog28$6,435
Omeprazole302$5,830

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$33$92,454100 claims
Novo NordiskOzempic, Rybelsus$223$86,90871 claims
MerckJanumet, Janumet Xr, Januvia$20$56,11554 claims
PfizerEliquis$200$27,41839 claims
GSKBreo Ellipta$101$14,57825 claims
AstraZenecaFarxiga$128$9,51612 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 1,680 family medicine providers in Alabama.

Other family medicine in Gardendale

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →